Cardiorespiratory Responses to Glittre ADL Test in Bronchiectasis: A Cross-Sectional Study

Ravoori Hena, Gopala Krishna Alaparthi, K. Shyam Krishnan, R. Anand, Vishak Acharya, Pretham Acharya

Research output: Contribution to journalArticle

Abstract

Background. Bronchiectasis is a chronic respiratory condition characterised by chronic sputum production, fatigue, and dyspnoea. These symptoms will lead to reduced exercise capacity and a reduced ability to carry out activities of daily living. Glittre ADL test is a valid and reliable test which evaluates the activities of daily living. Aim. To investigate whether the Glittre ADL test can differentiate the functional capacity and cardiorespiratory responses of patients with bronchiectasis from those healthy individuals using the six-minute test as a functional performance standard. Methods. This study included 30 subjects: 15 bronchiectasis and 15 age- and gender-matched healthy subjects. The patients and healthy subjects were made to perform the Glittre ADL and six-minute test on two consecutive days. Parameters such as time taken, distance walked, HR, RR, SpO2, and dyspnoea were recorded before and after the tests. Results. The performance of bronchiectasis was worse than the healthy group on the Glittre ADL test (4.78 ± 1.33 min, 3.94 ± 0.82 min, p=0.04). Distance walked in the six-minute walk test by the bronchiectasis was 42 meters lesser than the healthy (400.33 ± 77.99, 442 ± 89.21, p=0.18). The Glittre ADL test was correlated with 6MWT when the total sample was analysed (r=-0.41,p=0.05). There was moderate positive correlation between heart rate variation, dyspnoea, respiratory rate, and peripheral saturation (SpO2) between the tests (Glittre heart rate versus six-minute walk test heart rate (r=0.55,p=0.001); Glittre (Borg) versus six-minute walk test (Borg) (r=0.72,p=0.00); Glittre respiratory rate versus six-minute walk test RR (r=0.62,p=0.00); Glittre SpO2 versus six-minute walk test SpO2 (r=0.40,p=0.02)). The bronchiectasis group had a statistically significant higher (p=0.08,p=0.46) increase in dyspnoea and RR than the controls in both the Glittre ADL test and six-minute walk test (p=0.009,p=0.03), with the similar HR variation in both the groups (p>0.05). There was statistical difference in peripheral oxygen saturation in bronchiectasis in the six-minute walk test (p=0.03). Conclusion. The Glittre ADL test induced similar cardiorespiratory responses when compared to the six-minute walk test. So, the Glittre ADL test can be used as an assessment tool besides the six-minute walk test for the more complete evaluation of functional capacity and activities of daily living.

Original languageEnglish
Article number7470387
JournalCanadian Respiratory Journal
Volume2018
DOIs
Publication statusPublished - 01-01-2018

Fingerprint

Bronchiectasis
Activities of Daily Living
Cross-Sectional Studies
Dyspnea
Heart Rate
Respiratory Rate
Healthy Volunteers
Walk Test
Sputum
Fatigue
Exercise
Oxygen

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine

Cite this

@article{d12c154f427c4bcca9c032950fa5bfd0,
title = "Cardiorespiratory Responses to Glittre ADL Test in Bronchiectasis: A Cross-Sectional Study",
abstract = "Background. Bronchiectasis is a chronic respiratory condition characterised by chronic sputum production, fatigue, and dyspnoea. These symptoms will lead to reduced exercise capacity and a reduced ability to carry out activities of daily living. Glittre ADL test is a valid and reliable test which evaluates the activities of daily living. Aim. To investigate whether the Glittre ADL test can differentiate the functional capacity and cardiorespiratory responses of patients with bronchiectasis from those healthy individuals using the six-minute test as a functional performance standard. Methods. This study included 30 subjects: 15 bronchiectasis and 15 age- and gender-matched healthy subjects. The patients and healthy subjects were made to perform the Glittre ADL and six-minute test on two consecutive days. Parameters such as time taken, distance walked, HR, RR, SpO2, and dyspnoea were recorded before and after the tests. Results. The performance of bronchiectasis was worse than the healthy group on the Glittre ADL test (4.78 ± 1.33 min, 3.94 ± 0.82 min, p=0.04). Distance walked in the six-minute walk test by the bronchiectasis was 42 meters lesser than the healthy (400.33 ± 77.99, 442 ± 89.21, p=0.18). The Glittre ADL test was correlated with 6MWT when the total sample was analysed (r=-0.41,p=0.05). There was moderate positive correlation between heart rate variation, dyspnoea, respiratory rate, and peripheral saturation (SpO2) between the tests (Glittre heart rate versus six-minute walk test heart rate (r=0.55,p=0.001); Glittre (Borg) versus six-minute walk test (Borg) (r=0.72,p=0.00); Glittre respiratory rate versus six-minute walk test RR (r=0.62,p=0.00); Glittre SpO2 versus six-minute walk test SpO2 (r=0.40,p=0.02)). The bronchiectasis group had a statistically significant higher (p=0.08,p=0.46) increase in dyspnoea and RR than the controls in both the Glittre ADL test and six-minute walk test (p=0.009,p=0.03), with the similar HR variation in both the groups (p>0.05). There was statistical difference in peripheral oxygen saturation in bronchiectasis in the six-minute walk test (p=0.03). Conclusion. The Glittre ADL test induced similar cardiorespiratory responses when compared to the six-minute walk test. So, the Glittre ADL test can be used as an assessment tool besides the six-minute walk test for the more complete evaluation of functional capacity and activities of daily living.",
author = "Ravoori Hena and Alaparthi, {Gopala Krishna} and {Shyam Krishnan}, K. and R. Anand and Vishak Acharya and Pretham Acharya",
year = "2018",
month = "1",
day = "1",
doi = "10.1155/2018/7470387",
language = "English",
volume = "2018",
journal = "Canadian Respiratory Journal",
issn = "1198-2241",
publisher = "Pulsus Group Inc.",

}

Cardiorespiratory Responses to Glittre ADL Test in Bronchiectasis : A Cross-Sectional Study. / Hena, Ravoori; Alaparthi, Gopala Krishna; Shyam Krishnan, K.; Anand, R.; Acharya, Vishak; Acharya, Pretham.

In: Canadian Respiratory Journal, Vol. 2018, 7470387, 01.01.2018.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cardiorespiratory Responses to Glittre ADL Test in Bronchiectasis

T2 - A Cross-Sectional Study

AU - Hena, Ravoori

AU - Alaparthi, Gopala Krishna

AU - Shyam Krishnan, K.

AU - Anand, R.

AU - Acharya, Vishak

AU - Acharya, Pretham

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background. Bronchiectasis is a chronic respiratory condition characterised by chronic sputum production, fatigue, and dyspnoea. These symptoms will lead to reduced exercise capacity and a reduced ability to carry out activities of daily living. Glittre ADL test is a valid and reliable test which evaluates the activities of daily living. Aim. To investigate whether the Glittre ADL test can differentiate the functional capacity and cardiorespiratory responses of patients with bronchiectasis from those healthy individuals using the six-minute test as a functional performance standard. Methods. This study included 30 subjects: 15 bronchiectasis and 15 age- and gender-matched healthy subjects. The patients and healthy subjects were made to perform the Glittre ADL and six-minute test on two consecutive days. Parameters such as time taken, distance walked, HR, RR, SpO2, and dyspnoea were recorded before and after the tests. Results. The performance of bronchiectasis was worse than the healthy group on the Glittre ADL test (4.78 ± 1.33 min, 3.94 ± 0.82 min, p=0.04). Distance walked in the six-minute walk test by the bronchiectasis was 42 meters lesser than the healthy (400.33 ± 77.99, 442 ± 89.21, p=0.18). The Glittre ADL test was correlated with 6MWT when the total sample was analysed (r=-0.41,p=0.05). There was moderate positive correlation between heart rate variation, dyspnoea, respiratory rate, and peripheral saturation (SpO2) between the tests (Glittre heart rate versus six-minute walk test heart rate (r=0.55,p=0.001); Glittre (Borg) versus six-minute walk test (Borg) (r=0.72,p=0.00); Glittre respiratory rate versus six-minute walk test RR (r=0.62,p=0.00); Glittre SpO2 versus six-minute walk test SpO2 (r=0.40,p=0.02)). The bronchiectasis group had a statistically significant higher (p=0.08,p=0.46) increase in dyspnoea and RR than the controls in both the Glittre ADL test and six-minute walk test (p=0.009,p=0.03), with the similar HR variation in both the groups (p>0.05). There was statistical difference in peripheral oxygen saturation in bronchiectasis in the six-minute walk test (p=0.03). Conclusion. The Glittre ADL test induced similar cardiorespiratory responses when compared to the six-minute walk test. So, the Glittre ADL test can be used as an assessment tool besides the six-minute walk test for the more complete evaluation of functional capacity and activities of daily living.

AB - Background. Bronchiectasis is a chronic respiratory condition characterised by chronic sputum production, fatigue, and dyspnoea. These symptoms will lead to reduced exercise capacity and a reduced ability to carry out activities of daily living. Glittre ADL test is a valid and reliable test which evaluates the activities of daily living. Aim. To investigate whether the Glittre ADL test can differentiate the functional capacity and cardiorespiratory responses of patients with bronchiectasis from those healthy individuals using the six-minute test as a functional performance standard. Methods. This study included 30 subjects: 15 bronchiectasis and 15 age- and gender-matched healthy subjects. The patients and healthy subjects were made to perform the Glittre ADL and six-minute test on two consecutive days. Parameters such as time taken, distance walked, HR, RR, SpO2, and dyspnoea were recorded before and after the tests. Results. The performance of bronchiectasis was worse than the healthy group on the Glittre ADL test (4.78 ± 1.33 min, 3.94 ± 0.82 min, p=0.04). Distance walked in the six-minute walk test by the bronchiectasis was 42 meters lesser than the healthy (400.33 ± 77.99, 442 ± 89.21, p=0.18). The Glittre ADL test was correlated with 6MWT when the total sample was analysed (r=-0.41,p=0.05). There was moderate positive correlation between heart rate variation, dyspnoea, respiratory rate, and peripheral saturation (SpO2) between the tests (Glittre heart rate versus six-minute walk test heart rate (r=0.55,p=0.001); Glittre (Borg) versus six-minute walk test (Borg) (r=0.72,p=0.00); Glittre respiratory rate versus six-minute walk test RR (r=0.62,p=0.00); Glittre SpO2 versus six-minute walk test SpO2 (r=0.40,p=0.02)). The bronchiectasis group had a statistically significant higher (p=0.08,p=0.46) increase in dyspnoea and RR than the controls in both the Glittre ADL test and six-minute walk test (p=0.009,p=0.03), with the similar HR variation in both the groups (p>0.05). There was statistical difference in peripheral oxygen saturation in bronchiectasis in the six-minute walk test (p=0.03). Conclusion. The Glittre ADL test induced similar cardiorespiratory responses when compared to the six-minute walk test. So, the Glittre ADL test can be used as an assessment tool besides the six-minute walk test for the more complete evaluation of functional capacity and activities of daily living.

UR - http://www.scopus.com/inward/record.url?scp=85059521833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059521833&partnerID=8YFLogxK

U2 - 10.1155/2018/7470387

DO - 10.1155/2018/7470387

M3 - Article

VL - 2018

JO - Canadian Respiratory Journal

JF - Canadian Respiratory Journal

SN - 1198-2241

M1 - 7470387

ER -